Eunae Ko
Primary Care · New York, NYNPI 1003272865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Viiv Healthcare Company at 42.7% of the total. Reporting peaked in 2023 at $1,213 and has fallen 83.5% since, to $200 in 2025. Among primary care clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$665
- Johnson & Johnson$355
- Theratechnologies Inc.$316
- Janssen Products, LP$224
- EMD Serono, Inc.$205
- plus $409 from 9 others
What the payments were for
- Food & beverage$3,69697%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 63 | $1,621 |
| Gilead | 35 | $665 |
| Johnson & Johnson | 17 | $355 |
| Theratechnologies Inc. | 14 | $316 |
| Janssen Products, LP | 2 | $224 |
| EMD Serono, Inc. | 7 | $205 |
| Merck | 9 | $178 |
| AbbVie | 3 | $76 |
| GSK | 1 | $35 |
| Amgen | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Janssen Scientific Affairs, LLC | 2 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,795 in reported general payments places this provider in the 90th percentile of 239 primary care providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DovatoDolutegravir Sodium/Lamivudine | 32 | $88,883 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 16 | $68,071 |
| Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf) | 15 | $7,748 |
| Fluticasone Propionate | 12 | $131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyDovato | $1,621 | $88,88332 claims |
| GileadBiktarvy | $665 | $68,07116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 239 primary care providers in New York.
Other primary care in New York
- Dorothy KleinertNew York$27K
- Lisa PlanetaNew York$6K
- Erica StumpfNew York$4K
- Mona AboulnajaNew York$2K
- Kristl RamjattanNew York$2K
- Carl GastanesNew York$2K
- Yan Fon MeiNew York$2K
- Villicent UyNew York$2K
- Kathryn DowlingNew York$2K
- Stephanie KhanForest Hills$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.